• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fine-Gray 子分布风险模型可同时估计不同事件类型的绝对风险:累积总失效概率可能超过 1。

Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.

机构信息

ICES, Toronto, Ontario, Canada.

Institute of Health Management, Policy and Evaluation, University of Toronto, Toronto, Ontario, Canada.

出版信息

Stat Med. 2021 Aug 30;40(19):4200-4212. doi: 10.1002/sim.9023. Epub 2021 May 9.

DOI:10.1002/sim.9023
PMID:33969508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8360146/
Abstract

The Fine-Gray subdistribution hazard model has become the default method to estimate the incidence of outcomes over time in the presence of competing risks. This model is attractive because it directly relates covariates to the cumulative incidence function (CIF) of the event of interest. An alternative is to combine the different cause-specific hazard functions to obtain the different CIFs. A limitation of the subdistribution hazard approach is that the sum of the cause-specific CIFs can exceed 1 (100%) for some covariate patterns. Using data on 9479 patients hospitalized with acute myocardial infarction, we estimated the cumulative incidence of both cardiovascular death and non-cardiovascular death for each patient. We found that when using subdistribution hazard models, approximately 5% of subjects had an estimated risk of 5-year all-cause death (obtained by combining the two cause-specific CIFs obtained from subdistribution hazard models) that exceeded 1. This phenomenon was avoided by using the two cause-specific hazard models. We provide a proof that the sum of predictions exceeds 1 is a fundamental problem with the Fine-Gray subdistribution hazard model. We further explored this issue using simulations based on two different types of data-generating process, one based on subdistribution hazard models and other based on cause-specific hazard models. We conclude that care should be taken when using the Fine-Gray subdistribution hazard model in situations with wide risk distributions or a high cumulative incidence, and if one is interested in the risk of failure from each of the different event types.

摘要

在存在竞争风险的情况下,Fine-Gray 亚分布风险模型已成为估计随时间推移发生结果的发生率的默认方法。该模型很有吸引力,因为它直接将协变量与感兴趣事件的累积发生率函数(CIF)相关联。另一种方法是将不同的特定原因风险函数组合起来以获得不同的 CIF。亚分布风险方法的一个限制是,对于某些协变量模式,特定原因的 CIF 之和可能超过 1(100%)。使用 9479 名因急性心肌梗死住院的患者的数据,我们估计了每位患者的心血管死亡和非心血管死亡的累积发生率。我们发现,当使用亚分布风险模型时,大约有 5%的患者的 5 年全因死亡风险(通过将从亚分布风险模型获得的两个特定原因 CIF 组合获得)估计超过 1。通过使用两个特定原因的风险模型,可以避免这种现象。我们提供了一个证明,即预测的总和超过 1 是 Fine-Gray 亚分布风险模型的一个基本问题。我们进一步使用基于两种不同数据生成过程的模拟来探讨这个问题,一种基于亚分布风险模型,另一种基于特定原因的风险模型。我们的结论是,在风险分布广泛或累积发生率较高的情况下,以及如果对每种不同事件类型的失败风险感兴趣时,应谨慎使用 Fine-Gray 亚分布风险模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/71f3e8c50caf/SIM-40-4200-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/2f7e4685d6a4/SIM-40-4200-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/05cd7020a050/SIM-40-4200-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/a8ce68930665/SIM-40-4200-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/71f3e8c50caf/SIM-40-4200-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/2f7e4685d6a4/SIM-40-4200-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/05cd7020a050/SIM-40-4200-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/a8ce68930665/SIM-40-4200-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f916/8360146/71f3e8c50caf/SIM-40-4200-g003.jpg

相似文献

1
Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.Fine-Gray 子分布风险模型可同时估计不同事件类型的绝对风险:累积总失效概率可能超过 1。
Stat Med. 2021 Aug 30;40(19):4200-4212. doi: 10.1002/sim.9023. Epub 2021 May 9.
2
Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models.估计心血管疾病和其他事件的绝对风险:使用多个 Fine-Gray 亚分布风险模型的问题。
Circ Cardiovasc Qual Outcomes. 2022 Feb;15(2):e008368. doi: 10.1161/CIRCOUTCOMES.121.008368. Epub 2022 Jan 31.
3
On the relation between the cause-specific hazard and the subdistribution rate for competing risks data: The Fine-Gray model revisited.竞争风险数据中原因特异性风险与亚分布率之间的关系:再探 Fine-Gray 模型。
Biom J. 2020 May;62(3):790-807. doi: 10.1002/bimj.201800274. Epub 2020 Mar 4.
4
A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.时变协变量在 Fine-Gray 亚分布风险竞争风险回归模型中的应用综述。
Stat Med. 2020 Jan 30;39(2):103-113. doi: 10.1002/sim.8399. Epub 2019 Oct 29.
5
Practical recommendations for reporting Fine-Gray model analyses for competing risk data.关于报告竞争风险数据的Fine-Gray模型分析的实用建议。
Stat Med. 2017 Nov 30;36(27):4391-4400. doi: 10.1002/sim.7501. Epub 2017 Sep 15.
6
Survival analysis in the presence of competing risks.存在竞争风险时的生存分析。
Ann Transl Med. 2017 Feb;5(3):47. doi: 10.21037/atm.2016.08.62.
7
Propensity-score matching with competing risks in survival analysis.生存分析中存在竞争风险的倾向评分匹配。
Stat Med. 2019 Feb 28;38(5):751-777. doi: 10.1002/sim.8008. Epub 2018 Oct 22.
8
Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.竞争风险分析在改善射血分数降低的慢性心力衰竭失代偿患者预后评估中的应用。
J Clin Epidemiol. 2018 Nov;103:31-39. doi: 10.1016/j.jclinepi.2018.07.006. Epub 2018 Jul 27.
9
Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.针对特定病因累积发病率函数的直接似然推断:一种灵活的参数回归建模方法。
Stat Med. 2018 Jan 15;37(1):82-97. doi: 10.1002/sim.7498. Epub 2017 Oct 2.
10
Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.左截断和右删失情况下特定病因累积发病率估计及精细灰色模型
Biometrics. 2011 Mar;67(1):39-49. doi: 10.1111/j.1541-0420.2010.01420.x.

引用本文的文献

1
Multiple Imputation of Missing Covariates When Using the Fine-Gray Model.使用Fine-Gray模型时缺失协变量的多重填补
Stat Med. 2025 Jul;44(15-17):e70166. doi: 10.1002/sim.70166.
2
Development and temporal evaluation of sex-specific models to predict 4-year atherosclerotic cardiovascular disease risk based on age and neighbourhood characteristics in South Limburg, the Netherlands.基于荷兰南林堡的年龄和邻里特征开发特定性别的模型以预测4年动脉粥样硬化性心血管疾病风险并进行时间评估。
Diagn Progn Res. 2025 Jul 2;9(1):15. doi: 10.1186/s41512-025-00198-4.
3
The role of recipient sex in the post-liver transplant prognosis of acute-on-chronic liver failure.

本文引用的文献

1
Practical recommendations for reporting Fine-Gray model analyses for competing risk data.关于报告竞争风险数据的Fine-Gray模型分析的实用建议。
Stat Med. 2017 Nov 30;36(27):4391-4400. doi: 10.1002/sim.7501. Epub 2017 Sep 15.
2
Survival Analysis with Multiple Causes of Death: Extending the Competing Risks Model.多死因生存分析:扩展竞争风险模型
Epidemiology. 2017 Jan;28(1):12-19. doi: 10.1097/EDE.0000000000000531.
3
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.存在竞争风险时生存数据的分析导论
受者性别在慢性肝衰竭急性发作肝移植后预后中的作用。
J Liver Transpl. 2025 May;18. doi: 10.1016/j.liver.2025.100267. Epub 2025 Mar 23.
4
Beta-Blockers After PCI for Stable Coronary Artery Disease and Preserved Left Ventricular Ejection Fraction.经皮冠状动脉介入治疗后用于稳定型冠状动脉疾病及左心室射血分数保留患者的β受体阻滞剂
JACC Adv. 2025 Feb;4(2):101566. doi: 10.1016/j.jacadv.2024.101566. Epub 2025 Jan 17.
5
Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality.利用真实世界数据对2型糖尿病疾病进展进行建模:量化发病和死亡的竞争风险
CPT Pharmacometrics Syst Pharmacol. 2025 Mar;14(3):606-615. doi: 10.1002/psp4.13301. Epub 2025 Jan 17.
6
Time to nursing home admission and death in people with dementia: systematic review and meta-analysis.痴呆症患者入住养老院及死亡的时间:系统评价与荟萃分析。
BMJ. 2025 Jan 8;388:e080636. doi: 10.1136/bmj-2024-080636.
7
Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients.不同年龄组倾向性匹配患者中单纯机械瓣与生物瓣二尖瓣置换术的长期结果。
Eur J Cardiothorac Surg. 2024 Jul 1;66(1). doi: 10.1093/ejcts/ezae245.
8
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada.加拿大尼拉帕利用于卵巢癌维持治疗的真实世界安全性。
Curr Oncol. 2024 Jun 19;31(6):3591-3602. doi: 10.3390/curroncol31060264.
9
Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.前列腺癌治疗模式和死亡率的差异:黑种人和终末期肾病之间的相互作用。
Cancer Med. 2024 May;13(10):e7027. doi: 10.1002/cam4.7027.
10
Machine Learning Did Not Outperform Conventional Competing Risk Modeling to Predict Revision Arthroplasty.在预测翻修关节成形术方面,机器学习的表现并未优于传统的竞争风险模型。
Clin Orthop Relat Res. 2024 Aug 1;482(8):1472-1482. doi: 10.1097/CORR.0000000000003018. Epub 2024 Mar 12.
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.
4
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.竞争风险分析应报告所有病因特异性危害和累积发生率函数的结果。
J Clin Epidemiol. 2013 Jun;66(6):648-53. doi: 10.1016/j.jclinepi.2012.09.017. Epub 2013 Feb 14.
5
Constrained parametric model for simultaneous inference of two cumulative incidence functions.用于同时推断两个累积发病率函数的约束参数模型。
Biom J. 2013 Jan;55(1):82-96. doi: 10.1002/bimj.201200011. Epub 2012 Oct 23.
6
Absolute risk regression for competing risks: interpretation, link functions, and prediction.竞争风险的绝对风险回归:解释、链接函数和预测。
Stat Med. 2012 Dec 20;31(29):3921-30. doi: 10.1002/sim.5459. Epub 2012 Aug 2.
7
Regression trees for predicting mortality in patients with cardiovascular disease: what improvement is achieved by using ensemble-based methods?用于预测心血管疾病患者死亡率的回归树:使用基于集成的方法能带来哪些改善?
Biom J. 2012 Sep;54(5):657-73. doi: 10.1002/bimj.201100251. Epub 2012 Jul 6.
8
Competing risks and the clinical community: irrelevance or ignorance?竞争风险与临床界:无关紧要还是一无所知?
Stat Med. 2012 May 20;31(11-12):1089-97. doi: 10.1002/sim.4384. Epub 2011 Sep 23.
9
Modelling competing risks data with missing cause of failure.对存在缺失失效原因的竞争风险数据进行建模。
Stat Med. 2010 Dec 30;29(30):3172-85. doi: 10.1002/sim.4133.
10
Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial.公开报告卡对改善心脏护理质量的有效性:EFFECT研究:一项随机试验
JAMA. 2009 Dec 2;302(21):2330-7. doi: 10.1001/jama.2009.1731. Epub 2009 Nov 18.